Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BIMATOPROST RC - Health Canada Drug Approval Details

Approvals/Health Canada/BIMATOPROST RC

Authorized

STANDARD

BIMATOPROST RC

JUNO PHARMA CANADA INC.🇨🇦 Health Canada

Approval Date: Mar 30, 2026
Approval ID: 298f7bef7cc34933
Company: JUNO PHARMA CANADA INC.
Type: Standard

Approval Details

Approval Id: 298f7bef7cc34933
Drug Approval Canada Name: BIMATOPROST RC
Product Name: BIMATOPROST RC
Status: Marketed
Status Date: 2026-03-16
Original Market Date: 2026-03-16
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Ophthalmic
Schedule: PRESCRIPTION
Ahfs: 52:40.28
Atc Original: S01EE03 BIMATOPROST
Aig Number: 0147303002
Company Name: JUNO PHARMA CANADA INC.
Company Address: 11177 Hamon Montreal Quebec Canada H3M 3E4

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Mar 30, 2026

Approval ID

298f7bef7cc34933

Type

Standard

Back to Health Canada Approvals